PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.640.06 (1.08%)
5.46 - 5.64
4.95 - 8.28
2.0K / 2.4K (Avg.)
-282.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.32%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
8.60%
Positive gross profit growth while STERV.HE is negative. John Neff would see a clear operational edge over the competitor.
69.00%
Positive EBIT growth while STERV.HE is negative. John Neff might see a substantial edge in operational management.
69.00%
Positive operating income growth while STERV.HE is negative. John Neff might view this as a competitive edge in operations.
36.42%
Positive net income growth while STERV.HE is negative. John Neff might see a big relative performance advantage.
20.00%
Positive EPS growth while STERV.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
20.00%
Positive diluted EPS growth while STERV.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
13.68%
Slight or no buybacks while STERV.HE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
13.68%
Slight or no buyback while STERV.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-10.71%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
35.62%
Positive FCF growth while STERV.HE is negative. John Neff would see a strong competitive edge in net cash generation.
-32.58%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-20.63%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-1.38%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
259.95%
Positive long-term OCF/share growth while STERV.HE is negative. John Neff would see a structural advantage in sustained cash generation.
117.57%
5Y OCF/share CAGR above 1.5x STERV.HE's 36.54%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
190.16%
Positive 3Y OCF/share CAGR while STERV.HE is negative. John Neff might see a big short-term edge in operational efficiency.
0.00%
Below 50% of STERV.HE's 49.75%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-33.33%
Negative 5Y net income/share CAGR while STERV.HE is 17.83%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-40.00%
Negative 3Y CAGR while STERV.HE is 33.33%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
19.20%
10Y equity/share CAGR at 50-75% of STERV.HE's 34.77%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
24.65%
5Y equity/share CAGR at 75-90% of STERV.HE's 31.50%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
18.48%
3Y equity/share CAGR similar to STERV.HE's 18.65%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.35%
Firm’s AR is declining while STERV.HE shows 30.03%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-6.98%
Inventory is declining while STERV.HE stands at 4.33%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.79%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-13.40%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.07%
We’re deleveraging while STERV.HE stands at 0.41%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-14.50%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.